<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Nanion Technologies GmbH News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Nanion Technologies GmbH.</description>
		<lastBuildDate>Sat, 17 Oct 2026 01:37:30 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Nanion Technologies GmbH News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/20018.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/454109</guid>
			<title>Nanion Introduces NPC-Certified Cell Lines</title>
			<pubDate>Sat, 10 Nov 2012 03:00:00 -0500</pubDate>
			<description>Nanion now introduces “Nanion Approved Cells” where commercially available cell lines from several providers have been evaluated and certified based on cell and platform performance for automated patch clamp. [PR.com]</description>
			<link>https://www.pr.com/press-release/454109</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/392942</guid>
			<title>Nanion Introduces the Orbit 16 – a Pioneering Device for Parallel Lipid Bilayer Recordings</title>
			<pubDate>Fri, 24 Feb 2012 03:00:00 -0500</pubDate>
			<description>Nanion announces the introduction of a completely new product line for efficient analysis of bilayer-reconstituted ion channels and nanopores. The first of these, the Orbit 16, allows for automated formation of, and recordings from 16 bilayers in parallel, combining efficient data generation and ultra-high data quality. The Orbit 16 takes the pain out of bilayer recordings and facilitates efficient data generation through [PR.com]</description>
			<link>https://www.pr.com/press-release/392942</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/383734</guid>
			<title>Nanion Celebrates Its 10th Anniversary - Still with a Strong Focus on New Innovations</title>
			<pubDate>Tue, 17 Jan 2012 03:00:00 -0500</pubDate>
			<description>Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals. [PR.com]</description>
			<link>https://www.pr.com/press-release/383734</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/363732</guid>
			<title>Nanion Opens New Branch in China</title>
			<pubDate>Wed, 26 Oct 2011 03:00:00 -0400</pubDate>
			<description>Today, Nanion announces the opening of yet another branch. To meet the needs of the rapidly expanding number of customers in China, the dedicated sales- and support team in Beijing now opens the doors to Nanion Technologies China. [PR.com]</description>
			<link>https://www.pr.com/press-release/363732</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/354265</guid>
			<title>Nanion&#039;s Automated Patch Clamp Platforms Show Unparalleled Results Using Stem Cell Derived Cardiomyocytes</title>
			<pubDate>Sun, 18 Sep 2011 03:00:00 -0400</pubDate>
			<description>The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion’s platforms open up whole new avenues for compound safety testing. [PR.com]</description>
			<link>https://www.pr.com/press-release/354265</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/163255</guid>
			<title>Nanion is Winner of the Deutscher Gruenderpreis 2009</title>
			<pubDate>Sun, 05 Jul 2009 03:00:00 -0400</pubDate>
			<description>During the award ceremony in Berlin, Nanion was announced winner of the Deutscher Gründerpreis 2009. The Deutscher Gründerpreis is the most important award for outstanding entrepreneurs in Germany. The prize includes a coaching by Porsche Consulting and a mentorship for Nanion. The mentor for Nanion is Dr. Jürgen Heraeus, Chairman of the Supervisory Board of Heraeus Holding. [PR.com]</description>
			<link>https://www.pr.com/press-release/163255</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/160901</guid>
			<title>Nanion and Axiogenesis Present Parallel Patch Clamp Recordings of Action Potentials from Cor.At Cardiomyocytes</title>
			<pubDate>Thu, 25 Jun 2009 03:00:00 -0400</pubDate>
			<description>Stem cell derived cardiomyocytes were analyzed using Nanion’s automated patch clamp systems, the Patchliner and the Port-a-Patch to validate ion channel composition, the presence of action potentials and the effect of compounds on cardiac ion channels. [PR.com]</description>
			<link>https://www.pr.com/press-release/160901</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/127822</guid>
			<title>Nanion Nominated for the German Industry’s Innovation Award</title>
			<pubDate>Fri, 23 Jan 2009 03:00:00 -0500</pubDate>
			<description>Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed in this year’s Innovation Award and Nanion is finalist in the category “Start-Up Companies.” [PR.com]</description>
			<link>https://www.pr.com/press-release/127822</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/117527</guid>
			<title>Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot</title>
			<pubDate>Thu, 20 Nov 2008 03:00:00 -0500</pubDate>
			<description>Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion channel screening. [PR.com]</description>
			<link>https://www.pr.com/press-release/117527</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/55844</guid>
			<title>Nanion&#039;s Technology Nominated for Presidential Innovation Award</title>
			<pubDate>Sat, 13 Oct 2007 03:00:00 -0400</pubDate>
			<description>Nanion&#039;s Planar Patch Clamp Technology has been nominated for the German Future Award 2007 [PR.com]</description>
			<link>https://www.pr.com/press-release/55844</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/31102</guid>
			<title>Automated Internal Perfusion for the Port-a-Patch</title>
			<pubDate>Tue, 27 Feb 2007 03:00:00 -0500</pubDate>
			<description>Nanion Technologies introduces the Internal Perfusion System for the Port-a-Patch; a completely unique device for rapid, continuous and automated exchange of internal solutions during patch clamp recordings.   Using the internal perfusion system, ion channels regulated by internal binding sites for second messengers can be easily modulated or compounds acting on the internal side of the membrane like e.g. hERG active [PR.com]</description>
			<link>https://www.pr.com/press-release/31102</link>
			<dc:creator>Nanion Technologies GmbH</dc:creator>
		</item>
	</channel>
</rss>